Assembly Biosciences, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ASMB Nasdaq 2834 www.assemblybio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Assembly Biosciences, Inc.

Gilead Buys $20.1 Million of Assembly Biosciences Stock - Dec 29th, 2024 8:00 am
Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B - Dec 26th, 2024 1:00 pm
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs - Dec 19th, 2024 1:00 pm
Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates - Nov 13th, 2024 11:18 am
Assembly Biosciences: Q3 Earnings Snapshot - Nov 7th, 2024 11:19 pm
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates - Nov 7th, 2024 9:05 pm
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Oct 2nd, 2024 1:40 pm
Assembly Biosciences' Investigational Herpes Treatment Shows Safety In Healthy Participants (UPDATED) - Sep 23rd, 2024 5:39 pm
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 - Sep 23rd, 2024 12:00 pm
Is Assembly Biosciences (ASMB) Stock Outpacing Its Medical Peers This Year? - Sep 16th, 2024 1:40 pm
Is Sensus Healthcare (SRTS) Stock Outpacing Its Medical Peers This Year? - Aug 30th, 2024 1:40 pm
Individual investors in Assembly Biosciences, Inc. (NASDAQ:ASMB) are its biggest bettors, and their bets paid off as stock gained 14% last week - Aug 29th, 2024 10:33 am
Assembly Biosciences: Q2 Earnings Snapshot - Aug 8th, 2024 9:22 pm
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates - Aug 8th, 2024 8:05 pm
Investors in Assembly Biosciences (NASDAQ:ASMB) have unfortunately lost 90% over the last five years - Jul 19th, 2024 11:28 am
Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop - Jul 15th, 2024 12:00 pm
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection - Jun 18th, 2024 12:00 pm
Assembly Biosciences Announces $12.6 Million in Equity Financings - Jun 17th, 2024 12:00 pm
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366 - Jun 10th, 2024 12:00 pm
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024 - Jun 5th, 2024 12:00 pm